ACR 66: Diabetes and Cardiovascular Disease Awareness Month.
- Session Year: 2017-2018
- House: Assembly
- Latest Version Date: 2017-06-06
This measure would declare May 2017 as Diabetes and Cardiovascular Disease Awareness Month.
This measure would declare May 2017 as Diabetes and Cardiovascular Disease Awareness Month.
This measure would declare May 2017 as Diabetes and Cardiovascular Disease Awareness Month.
WHEREAS, Diabetes affects more than 29 million Americans and is a chronic condition that occurs when the body does not properly produce or use the hormone insulin that regulates blood sugar; and
WHEREAS, Type II diabetes is the most common type of diabetes, representing an estimated 90 to 95 percent of all diagnosed adult diabetes cases in the United States; and
WHEREAS, Diabetes is the seventh leading cause of death in the United States with 8 million Americans undiagnosed and more than 5,000 Americans diagnosed each day; and
WHEREAS, Cardiovascular disease is the leading cause of death associated with diabetes due to complications associated with diabetes, such as high blood sugar, high blood pressure, and obesity; and
WHEREAS, Cardiovascular disease is a term used to define problems with the heart and blood vessels such as heart attacks, heart failure, and strokes; and
WHEREAS, People with type II diabetes are at two to four times greater risk for developing cardiovascular disease, and findings from a recent study reveal that 52 percent of adults living with type II diabetes are unaware they are at an increased risk; and
WHEREAS, Two out of three deaths in people with type II diabetes are attributed to cardiovascular disease in the United States, accounting for 68 percent of deaths in people with type II diabetes; and
WHEREAS, The total health care costs for the treatment of diabetes were reported to be approximately $245 billion annually, with the direct medical costs accounting for $176 billion of the total costs, in 2013, and cardiovascular disease accounting for 28 percent of the costs for treating diabetes patients; and
WHEREAS, In the State of California, 46 percent of the population is considered to have prediabetes and 9 percent to have diabetes, totaling 55 percent of the population of the state; and
WHEREAS, In the State of California, the amount paid by Medicare for type II diabetes and cardiovascular disease totals $3,557,889,730, with prevalence reaching 8.1 percent; and
WHEREAS, Twelve and one-fifth percent of the Hispanic population in Californias Medicare community are diagnosed with type II diabetes and cardiovascular disease, and the amount paid by Medicare in the state totals $413,068,129 for 1,110 beneficiaries; and
WHEREAS, Eleven and nine-tenths percent of the African American population in Californias Medicare community are diagnosed with type II diabetes and cardiovascular disease, and the amount paid by Medicare in the state totals $372,284,357 for 931 beneficiaries; and
WHEREAS, Ten and seven-tenths percent of other populations, including Asian, Hawaiian, and Native American, in Californias Medicare community are diagnosed with type II diabetes and cardiovascular disease, and the amount paid by Medicare in the state totals $589,947,884 for 2,149 beneficiaries; and
WHEREAS, Seven percent of the Caucasian population in Californias Medicare community are diagnosed with type II diabetes and cardiovascular disease, and the amount paid by Medicare in the state totals $2,182,589,361 for 7,198 beneficiaries; and
WHEREAS, Seven and one-half percent of the female population in Californias Medicare community are diagnosed with type II diabetes and cardiovascular disease, and the amount paid by Medicare in the state totals $1,700,006,646 for 5,661 beneficiaries; and
WHEREAS, Appropriate awareness and education about the cardiovascular risks associated with diabetes can effectively reduce the overall outcome and financial burden of the illness; and
WHEREAS, The Partnership to Fight Chronic Disease and other relevant partners seek to promote awareness, education, and action related to diabetes and the link to cardiovascular disease; now, therefore, be it
Resolved by the Assembly of the State of California, the Senate thereof concurring, That the Legislature declares May 2017 as Diabetes and Cardiovascular Disease Awareness Month and encourages others to promote education and awareness of the connection between diabetes and cardiovascular disease; and be it further
Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.
WHEREAS, Diabetes affects more than 29 million Americans and is a chronic condition that occurs when the body does not properly produce or use the hormone insulin that regulates blood sugar; and
WHEREAS, Type II diabetes is the most common type of diabetes, representing an estimated 90 to 95 percent of all diagnosed adult diabetes cases in the United States; and
WHEREAS, Diabetes is the seventh leading cause of death in the United States with 8 million Americans undiagnosed and more than 5,000 Americans diagnosed each day; and
WHEREAS, Cardiovascular disease is the leading cause of death associated with diabetes due to complications associated with diabetes, such as high blood sugar, high blood pressure, and obesity; and
WHEREAS, Cardiovascular disease is a term used to define problems with the heart and blood vessels such as heart attacks, heart failure, and strokes; and
WHEREAS, People with type II diabetes are at two to four times greater risk for developing cardiovascular disease, and findings from a recent study reveal that 52 percent of adults living with type II diabetes are unaware they are at an increased risk; and
WHEREAS, Two out of three deaths in people with type II diabetes are attributed to cardiovascular disease in the United States, accounting for 68 percent of deaths in people with type II diabetes; and
WHEREAS, The total health care costs for the treatment of diabetes were reported to be approximately $245 billion annually, with the direct medical costs accounting for $176 billion of the total costs, in 2013, and cardiovascular disease accounting for 28 percent of the costs for treating diabetes patients; and
WHEREAS, In the State of California, 46 percent of the population is considered to have prediabetes and 9 percent to have diabetes, totaling 55 percent of the population of the state; and
WHEREAS, In the State of California, the amount paid by Medicare for type II diabetes and cardiovascular disease totals $3,557,889,730, with prevalence reaching 8.1 percent; and
WHEREAS, Twelve and one-fifth percent of the Hispanic population in Californias Medicare community are diagnosed with type II diabetes and cardiovascular disease, and the amount paid by Medicare in the state totals $413,068,129 for 1,110 beneficiaries; and
WHEREAS, Eleven and nine-tenths percent of the African American population in Californias Medicare community are diagnosed with type II diabetes and cardiovascular disease, and the amount paid by Medicare in the state totals $372,284,357 for 931 beneficiaries; and
WHEREAS, Ten and seven-tenths percent of other populations, including Asian, Hawaiian, and Native American, in Californias Medicare community are diagnosed with type II diabetes and cardiovascular disease, and the amount paid by Medicare in the state totals $589,947,884 for 2,149 beneficiaries; and
WHEREAS, Seven percent of the Caucasian population in Californias Medicare community are diagnosed with type II diabetes and cardiovascular disease, and the amount paid by Medicare in the state totals $2,182,589,361 for 7,198 beneficiaries; and
WHEREAS, Seven and one-half percent of the female population in Californias Medicare community are diagnosed with type II diabetes and cardiovascular disease, and the amount paid by Medicare in the state totals $1,700,006,646 for 5,661 beneficiaries; and
WHEREAS, Appropriate awareness and education about the cardiovascular risks associated with diabetes can effectively reduce the overall outcome and financial burden of the illness; and
WHEREAS, The Partnership to Fight Chronic Disease and other relevant partners seek to promote awareness, education, and action related to diabetes and the link to cardiovascular disease; now, therefore, be it
Resolved by the Assembly of the State of California, the Senate thereof concurring, That the Legislature declares May 2017 as Diabetes and Cardiovascular Disease Awareness Month and encourages others to promote education and awareness of the connection between diabetes and cardiovascular disease; and be it further
Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.
WHEREAS, Diabetes affects more than 29 million Americans and is a chronic condition that occurs when the body does not properly produce or use the hormone insulin that regulates blood sugar; and
WHEREAS, Type II diabetes is the most common type of diabetes, representing an estimated 90 to 95 percent of all diagnosed adult diabetes cases in the United States; and
WHEREAS, Diabetes is the seventh leading cause of death in the United States with 8 million Americans undiagnosed and more than 5,000 Americans diagnosed each day; and
WHEREAS, Cardiovascular disease is the leading cause of death associated with diabetes due to complications associated with diabetes, such as high blood sugar, high blood pressure, and obesity; and
WHEREAS, Cardiovascular disease is a term used to define problems with the heart and blood vessels such as heart attacks, heart failure, and strokes; and
WHEREAS, People with type II diabetes are at two to four times greater risk for developing cardiovascular disease, and findings from a recent study reveal that 52 percent of adults living with type II diabetes are unaware they are at an increased risk; and
WHEREAS, Two out of three deaths in people with type II diabetes are attributed to cardiovascular disease in the United States, accounting for 68 percent of deaths in people with type II diabetes; and
WHEREAS, The total health care costs for the treatment of diabetes were reported to be approximately $245 billion annually, with the direct medical costs accounting for $176 billion of the total costs, in 2013, and cardiovascular disease accounting for 28 percent of the costs for treating diabetes patients; and
WHEREAS, In the State of California, 46 percent of the population is considered to have prediabetes and 9 percent to have diabetes, totaling 55 percent of the population of the state; and
WHEREAS, In the State of California, the amount paid by Medicare for type II diabetes and cardiovascular disease totals $3,557,889,730, with prevalence reaching 8.1 percent; and
WHEREAS, Twelve and one-fifth percent of the Hispanic population in Californias Medicare community are diagnosed with type II diabetes and cardiovascular disease, and the amount paid by Medicare in the state totals $413,068,129 for 1,110 beneficiaries; and
WHEREAS, Eleven and nine-tenths percent of the African American population in Californias Medicare community are diagnosed with type II diabetes and cardiovascular disease, and the amount paid by Medicare in the state totals $372,284,357 for 931 beneficiaries; and
WHEREAS, Ten and seven-tenths percent of other populations, including Asian, Hawaiian, and Native American, in Californias Medicare community are diagnosed with type II diabetes and cardiovascular disease, and the amount paid by Medicare in the state totals $589,947,884 for 2,149 beneficiaries; and
WHEREAS, Seven percent of the Caucasian population in Californias Medicare community are diagnosed with type II diabetes and cardiovascular disease, and the amount paid by Medicare in the state totals $2,182,589,361 for 7,198 beneficiaries; and
WHEREAS, Seven and one-half percent of the female population in Californias Medicare community are diagnosed with type II diabetes and cardiovascular disease, and the amount paid by Medicare in the state totals $1,700,006,646 for 5,661 beneficiaries; and
WHEREAS, Appropriate awareness and education about the cardiovascular risks associated with diabetes can effectively reduce the overall outcome and financial burden of the illness; and
WHEREAS, The Partnership to Fight Chronic Disease and other relevant partners seek to promote awareness, education, and action related to diabetes and the link to cardiovascular disease; now, therefore, be it
Resolved by the Assembly of the State of California, the Senate thereof concurring, That the Legislature declares May 2017 as Diabetes and Cardiovascular Disease Awareness Month and encourages others to promote education and awareness of the connection between diabetes and cardiovascular disease; and be it further
Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.
|
Date
|
Status
|
|---|---|
| Jun 6, 2017 | Chaptered by Secretary of State - Res. Chapter 60, Statutes of 2017. |
| Jun 6, 2017 | Enrolled and filed with the Secretary of State at 11 a.m. |
| May 26, 2017 | In Assembly. Ordered to Engrossing and Enrolling. |
| May 26, 2017 | Adopted and to Assembly. (Ayes 37. Noes 0. Page 1225.) |
| May 23, 2017 | Ordered to special consent calendar. |
| May 17, 2017 | From committee: Ordered to third reading. |
| May 8, 2017 | In Senate. To Com. on RLS. |
| May 4, 2017 | Coauthors revised. |
| Apr 27, 2017 | From committee: Be adopted. Ordered to Third Reading. (Ayes 9. Noes 0.) (April 27). |
| Apr 24, 2017 | Referred to Com. on RLS. |
| Apr 21, 2017 | From printer. |
| Apr 20, 2017 | Introduced. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| May 26, 2017 | Special Consent Calendar # ACR66 | Senate Floor |
Passed |
|
| Apr 27, 2017 | Be adopted. To third reading. | Assembly Standing Committee on Rules |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
|
Organization
|
Position
|
Date
|
|---|---|---|
| AFSCME, AFL-CIO | ** Support | May 17, 2017 |
| boehringer ingelheim pharmaceuticals | ** Support | May 17, 2017 |
| California Life Sciences Association | ** Support | May 17, 2017 |
| California Society For Respiratory Care | ** Support | May 17, 2017 |
| California State Alliance Of YmcaS | ** Support | May 17, 2017 |
| Partnership to Fight Chronic Disease | ** Support | May 17, 2017 |
Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | ACR 66 |
THIRD READING
Bill No: ACR 66
Introduced: 4/20/17
ASSEMBLY FLOOR: Read and adopted, 5/4/17
SUBJECT: Diabetes and Cardiovascular Disease Awareness Month
DIGEST:
This resolution declares May 2017 as Diabetes and Cardiovascular Disease Awareness Month.
ANALYSIS: This resolution makes the following legislative findings:
- Diabetes affects more than 29 million Americans and is a chronic condition. It is the seventh leading cause of death in the U.S. with 8 million Americans undiagnosed and more than 5,000 Americans diagnosed each day. Type II diabetes is the most common type of diabetes, representing an estimated 90-95% of all diagnosed adult diabetes cases in the U.S.
- Cardiovascular disease is the leading cause of death associated with diabetes due to complications associated with diabetes, such as high blood sugar, high blood pressure, and obesity. Cardiovascular disease is a term used to define problems with the heart and blood vessels.
- People with type II diabetes are at two to four times greater risk for developing cardiovascular disease, and findings from a recent study reveal that 52% of adults living with type II diabetes are unaware they are at an increased risk.
- Two out of three deaths in people with type II diabetes are attributed to cardiovascular disease in the U.S., accounting for 68% of deaths in people with type II diabetes.
- The total health care costs for the treatment of diabetes were reported to be approximately $245 billion annually, with the direct medical costs accounting for $176 billion of the total costs, in 2013, and cardiovascular disease accounting for 28% of the costs for treating diabetes patients.
- In California, 46% of the population is considered to have prediabetes and 9% to have diabetes, totaling 55% of the population of the state.
- In California, the amount paid by Medicare for type II diabetes and cardiovascular disease totals $3,557,889,730, with prevalence reaching 8.1%.
- Appropriate awareness and education about the cardiovascular risks associated with diabetes can effectively reduce the overall outcome and financial burden of the illness.
This resolution declares May 2017 as Diabetes and Cardiovascular Disease Awareness Month and encourages others to promote education and awareness of the connection between diabetes and cardiovascular disease.
Related/Prior Legislation
SR 37 (Hertzberg, 2017) declares November 2017 as Diabetes Awareness Month; and encourages individuals to seek screening to understand their diabetes risk, and to pursue early treatment if necessary, in order to reduce the incidence of diabetes and its complications. The resolution is on Senate Third Reading.
FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No
AFSCME, AFL-CIO
Boehringer Ingelheim Pharmaceuticals
California Life Sciences Association
California Society for Respiratory Care
California State Alliance of YMCAs
Partnership to Fight Chronic Disease
OPPOSITION: (Verified 5/16/17)
None received
Prepared by: Melissa Ward / SFA / (916) 651-1520
5/17/17 16:10:39
**** END ****
ASSEMBLY THIRD READING
ATR Bill Id:ACR 66
Author:(Daly)
As Introduced Ver:April 20, 2017
Majority vote
Committee | Votes | Ayes | Noes |
Rules | 9-0 | Cooley, Cunningham, Brough, Chen, Friedman, Grayson, Levine, Nazarian, Salas |
SUMMARY: Declares the month of May 2017 as Diabetes and Cardiovascular Disease Awareness Month. Specifically, this resolution makes the following legislative findings:
- Diabetes affects more than 29 million Americans and is a chronic condition that occurs when the body does not properly produce or use the hormone insulin that regulates blood sugar. Type II diabetes is the most common type of diabetes, representing an estimated 90% to 95% of all diagnosed adult diabetes cases in the United States.
- Diabetes is the seventh leading cause of death in the United States with 8 million Americans undiagnosed and more than 5,000 Americans diagnosed each day.
- Cardiovascular disease is the leading cause of death associated with diabetes due to complications associated with diabetes, such as high blood sugar, high blood pressure, and obesity. People with type II diabetes are at two to four times great risk for developing cardiovascular disease, and findings from a recent study reveal that 52% of adults living with type II diabetes are unaware they are at an increased risk.
- The total health care costs for the treatment of diabetes were reported to be approximately $245 billion annually, with the direct medical costs accounting for $176 billion of the total costs, in 2013, and cardiovascular disease accounting for 28% of the costs for treating diabetes patients.
- In the State of California, the amount paid by Medicare for type II diabetes and cardiovascular disease totals $3,557,889,730, with prevalence reaching 8.1%.
- Appropriate awareness and education about the cardiovascular risks associated with diabetes can effectively reduce the overall outcome and financial burden of the illness. The Partnership to Fight Chronic Disease and other relevant partners seek to promote awareness, education, and action related to diabetes and the link to cardiovascular disease.
FISCAL EFFECT: None
Analysis Prepared by: Nicole Willis / RLS. / (916) 319-2800 FN: 0000187
Date of Hearing: April 27, 2017
ASSEMBLY COMMITTEE ON RULES
Ken Cooley, Chair
ABPCA Bill Id:ACR 66
Author:(Daly) – As Introduced Ver:April 20, 2017
SUBJECT: Diabetes and Cardiovascular Disease Awareness Month
SUMMARY: Declares the month of May 2017 as Diabetes and Cardiovascular Disease Awareness Month. Specifically, this resolution makes the following legislative findings:
- Diabetes affects more than 29 million Americans and is a chronic condition that occurs when the body does not properly produce or use the hormone insulin that regulates blood sugar. Type II diabetes is the most common type of diabetes, representing an estimated 90 to 95 percent of all diagnosed adult diabetes cases in the United States.
- Diabetes is the seventh leading cause of death in the United States with 8 million Americans undiagnosed and more than 5,000 Americans diagnosed each day.
- Cardiovascular disease is the leading cause of death associated with diabetes due to complications associated with diabetes, such as high blood sugar, high blood pressure, and obesity. People with type II diabetes are at two to four times great risk for developing cardiovascular disease, and findings from a recent study reveal that 52 percent of adults living with type II diabetes are unaware they are at an increased risk.
- The total health care costs for the treatment of diabetes were reported to be approximately $245 billion annually, with the direct medical costs accounting for $176 billion of the total costs, in 2013, and cardiovascular disease accounting for 28 percent of the costs for treating diabetes patients.
- In the State of California, the amount paid by Medicare for type II diabetes and cardiovascular disease totals $3,557,889,730, with prevalence reaching 8.1 percent.
- Appropriate awareness and education about the cardiovascular risks associated with diabetes can effectively reduce the overall outcome and financial burden of the illness. The Partnership to Fight Chronic Disease and other relevant partners seek to promote awareness, education, and action related to diabetes and the link to cardiovascular disease.
FISCAL EFFECT: None
REGISTERED SUPPORT / OPPOSITION:
Support
Partnership to Fight Chronic Disease (PFCD)
Opposition
None on file
Analysis Prepared by: Nicole Willis / RLS. / (916) 319-2800
Bill Author
Bill Co-Author(s):